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Abstract
Background: Colorectal cancer is the third most common cancer in Iran. The increasing trend of colorectal cancer
incidence in Iran and the close relationship with the geographical location are the underlying reasons for this study.
Methods: Data source: Eleven databases, including MEDLINE, EMBASE, SCOPUS, and four other databases, for
articles in Persian were searched from April 2014 to October 2014. Additional data were obtained from an online
survey of the Central Library of Tabriz Faculty of Medicine. Study eligibility criteria: In this systematic review and
meta-analysis, we included studies reporting different measures of incidence, age-standardized incidence rates, and
crude incidence rates. All rates (per 100,000 person-years) were standardized to the world standard population.
Study appraisal and synthesis methods: A preliminary review of the title and abstracts of these articles was used to
exclude any that were clearly irrelevant. The full text review determined whether the article was relevant to our
topic. All the potentially relevant manuscripts were reviewed by two other investigators (S.D., M.G.). A total of 39
studies (10 Persian and 29 English articles) from different provinces and diverse areas of Iran, were analyzed in this
study using comprehensive meta-analysis software. For accuracy studies, we used estimated rates for males and
females with 95 % confidence intervals.
Results: Age-standardized incidence rates were obtained based on the random effects model and were 8.16
(95 % CI: 6.64 to 9.68) and 6.17 (95 % CI: 5.01 to 7.32) for males and females, respectively. The random crude rates
were 5.58 (95 % CI: 4.22 to 6.94) for males and 4.01 (95 % CI: 3.06 to 4.97) for females.
Conclusions: Colorectal cancer incidence rates rise due to individual and environmental risk factors as well as
improvement in the registry system and increase in access to health services. A more executed organized and
structured system for collecting cancer data, in all cities and rural areas of the country, is an essential priority.
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Background
Cancer is one of the major global health problems, and its
importance is on the rise in Iran as well. Cancer is the
third most common mortality factor, and the second
largest group of chronic non-communicable diseases in
Iran. Cancer of the colon and rectum is one of the leading
causes of cancer-related deaths in the Western countries,
and colorectal cancer (CRC) is the third most common
cause of cancer death in the world [1]. Colorectal cancer
is the third most common cancer in Iran. The incidence
of CRC significantly varies depending on the geographical
regions. It varies at least 10 times in different regions of
the world and has a significant time trend [2–4]. Further-
more, there is a significant difference in the incidence and
mortality rates between different racial and ethnic groups
[2]. While the annual incidence rate of CRC is 30–50/
100,000 individuals in North America and Europe, it is
about 37/100,000 in most Middle-Eastern countries.
Cultural changes in the third-world countries have
led to a rapid increase in the incidence of CRC in
these countries [5, 6].
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The National Cancer Registry Program in Iran
(INCRS) was started in 2000, and its results have pro-
vided an important source of information for cancer
studies in the country. This is pathology-based program
with >85 % of the expected number of cancers being
registered. According to the information obtained from
this source, there is a significant difference in the inci-
dence rates of CRC in different parts of Iran. According
to the annual report of INCRS, CRC is the fourth com-
mon cancer in men after stomach, bladder, and prostate
cancer and the second among women after breast cancer
(besides melanoma) [7–10].
Recent studies have shown a rapid rise in the inci-
dence of colorectal cancer in Iran [11, 12]. In a study
done about 35 years ago in Iran, the estimated annual
incidence rate of CRC was 1.5–5.5/100,000 individuals
[1, 13]. A research study conducted in 2008 reported an
age-standardized incidence rates (ASR) of 7–8 (per
100,000) for both males and females and further stated
that 5000 new cases of CRC (7 per 100,000 individuals)
are annually reported from Iran [1]. Of these 5000 cases,
2262 die annually because of CRC [3, 8, 9]. This is
higher than that of previous reports in Iran, while it is
closer to the statistics reported from other Middle East
areas, and less than the rates in western countries [8, 14]
. A recent study conducted in the North West of Iran in
2014 reported that the annual ASR were estimated to be
11.2 and 8.93 in men and women, respectively, and the
respective crude rates (CR) were 11.5 and 9.22 [12, 15].
As compared to western countries, the incidence of
colorectal cancer in Iran is low, but it seems to have in-
creased significantly during the past decade [11, 12, 16].
There is a wide geographical variation in the incidence of
cancers within the 31 different provinces in Iran. In
addition, there are significant variations in the infrastruc-
ture and capacities of these provinces. A close relationship
between cancer and the geographical location is also the
underlying reason for this emerging trend, and the in-
creased colorectal cancer incidence in geographically di-
verse areas of Iran [10]. The rising incidence and mortality
rates of colorectal cancer demand a systematic approach
toward a specific and national research program in Iran.
Statistical data should be accurately and sufficiently up-
dated periodically to identify the trends in the incidence,
prevalence, and mortality of colorectal cancer in Iran. The
aim of this systematic review and meta-analysis, was to re-
port and analyze the different measures of incidence, age-
standardized incidence rates and crude incidence rates of
colorectal cancer from different areas of Iran.
Methods
Protocol and registration
This systematic review and meta-analysis adhere to the
PRISMA guideline. As this study did not include any
clinical trials nor compare between groups, we did not
register it in the Cochrane library.
Eligibility criteria
A preliminary review of the title and abstracts of articles
was performed to exclude any irrelevant evidence. Full-text
review was performed to determine whether the article is
relevant to the study topic. All the potentially relevant
manuscripts were reviewed by two other investigators
(S.D., M.G.).
Abstracts or any unpublished studies such as thesis
and reports were not considered in the analysis. Both
English and Persian language articles were included in
this study.
Information sources
The databases PubMed and PMC, MEDLINE, EMBASE,
SCOPUS, and Google Scholar were searched for articles
in English and SID, Magiran, Medlib, and Irandoc for
articles in Persian from April 2014 to October 2014. The
reference lists of the obtained articles were searched to
identify any additional relevant articles on the same
topic. If the results of the study did not report ASRs
and/or CRs in the primary article, we tried to contact
the author for the information by email. In some cases,
due to old date of the study and inaccessibility to elec-
tronic files, we requested the journals’ editorial office to
send us the paper files via Fax.
Search
For retrieving the published papers to identify the stud-
ies of interest, we conducted a computerized literature
search. We used medical subject headings to identify all
the relevant articles. The search terms were as follows:
Colorectal Cancer (colorectal OR colorectum OR colon
OR rectum OR bowel), Incidence Rate (Incidence OR
age standardized rate OR ASR OR Crude Incidence
Rate), Iran, Epidemiologic study, Characteristics, and
Distribution.
Study selection
Our selection criteria were any epidemiologic, analytic,
descriptive, clinical, cross-sectional, and population-
based studies including information about age, gen-
der, and subsite of CRC in the different provinces of
Iran. We included any results from January 2000 to
October 2014.
Inclusion was not otherwise restricted by study size or
language. Studies in which gender was not applied in the
measures of incidence rate were excluded from the meta-
analysis. We included the studies in which the overall inci-
dence rates for colon and rectum cancers were reported.
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Data collection process
We also included the studies reporting different measures
of incidence, age-standardized incidence rate, and crude
incidence rates in this meta-analysis. Two reviewers (R.D.,
S.D.) abstracted the data to a predefined form. After com-
puting the rate estimate for each study, we created a more
complex model.
Data items
The following data were collected from each study: The
first author’s last name, publication date, and the province
of origin; study cases and target population; duration of
the study; characteristics of the study subjects (distribu-
tion according to age and gender); age-standardized inci-
dence rate and crude incidence rate; anatomical subsite:
cancers of the cecum, appendix, ascending colon, hepatic
flexure of colon, and transverse colon were categorized as
Right Side Tumors, and cancers of splenic flexure of the
colon, descending colon, and sigmoid colon were catego-
rized as Left Side Tumors. Cancers of the rectum and
rectosigmoid were categorized as Rectal Cancers.
Risk of bias in individual studies
Our data sources were primarily based on the Iranian
National Cancer Registry System reports with a coverage
rate of more than 85 % of cancer cases in the country
[10]. The primary outcome was therefore identical in all
the studies. Three studies were excluded due to the lack
of sufficient data.
Summary measures
The actual risks of cancers are better described by the
age-standardized rate and the overall number of cancer
cases each year, or the crude incidence rate. Therefore,
the terms used to determine the outcome were Age-
Standardized Incidence Rate (ASR) and/or Crude Inci-
dence Rate (CR) of Colorectal Cancer. All ASRs and
CRs per 100,000 person-years were obtained and stan-
dardized to the world standard population in all of the
studies. If more than one ASR and/or CR was reported
in a study, we used the latest data in the meta-analysis.
ASRs were not reported in 11 studies, for which we
calculated the ASR by direct standardization method
using world standard population, in the different age
and sex groups per 100,000 population [17]. The target
population of each province was obtained from the
recent data of the general census statistics of Iran [18].
Synthesis of results
All the analyses were performed using the Comprehensive
Meta-Analysis software, version 2.2 (Biostat, Englewood,
New Jersey). Random effects models were used to calcu-
late the ASR and CR incidence rates with 95 % confidence
intervals; P < 0.05 was considered to be statistically
significant. Forest plots were made for males and females
separately for ASR and CR. Heterogeneity across the stud-
ies was assessed with the Cochran’s Q statistic-value, I2
Index, and degree of freedom (df), and P < 0.10 was con-
sidered to be statistically significant. The following thresh-
olds were considered for the interpretation of I2 Index: 0
to 40 %: might not be important, 30 to 60 %: may present
moderate heterogeneity, 50 to 90 %: may present substan-
tial heterogeneity, and 70 to 100 %: considerable hetero-
geneity [19].
Risk of bias across studies
Although the results of the random effects models did
not show a considerably significant difference, we used
the random effect model for minimizing the risk of bias
across the studies [20, 21].
Consent statement
As this is a systematic review and meta-analysis, we did
not include any humans and/or animals. This study was




Most of the data were retrieved from the Iranian Cancer
Registry System, which collects the epidemiologic and
clinical data of all newly diagnosed cancer cases. After
excluding 26 duplicate studies, we included 39 studies,
comprising 10 Persian and 29 English articles, conducted
in different provinces and areas of the country, pub-
lished from 2010 to 2014. Figure 1 shows the flow chart
of the searches done for identifying the published and
reported cases included in this study.
Study characteristics
A total of 44 studies were included in this analysis.
Among these, 33 studies reported age-standardized inci-
dence rates and 24 studies reported crude incidence
rates for both males and females. In addition, 8 studies
reported the ASR results and the overall rates for both
men and women and 16 studies summarized the ASRs
as an overall rate. Moreover, 24 studies reported the
overall ASRs, in which gender was not considered in the
measures of incidence rates. These studies did not meet
the inclusion criteria of the study, and we did not
include them in the meta-analysis reports. The charac-
teristics of the included studies are summarized in
Table 1. All the estimated rates in whole parts of the
study have been reported per 100,000 persons, and so
the repetitions were ignored.
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Risk of bias within studies
We did not check for any risk of bias within the studies,
as the statistical analysis methods used for calculating
the age-standardized incidence rate and crude rate mea-
surements were identical in all the studies. We reported
age-standardized (ASR) and crude incidence rates (CR)
for men and women separately. If ASRs or CRs of a
study were reported several times over the years, we
took the latest rates [6, 22]. If a particular study reported
the ASRs and/or CRs from different provinces in a
report, we considered the reports in each province as a
separate study in the analysis of data [6, 22].
Results of individual studies
The highest ASR was reported from Tehran for males
(16.4) [23] and from Zahedan for females (13.25) [24]
during 2000–2014, where the overall ASRs obtained
from the reports exceeded by a maximum rate of 12.60
and a minimum rate of 1.37. The CRs vary from 11.5 to
1.1 in men and 9.22 to 1.20 in women.
Synthesis of results
The overall ASRs of colorectal cancer in both males and
females were obtained from 21 studies. Based on the
random effect model, the ASR was 5.92, 95 % CI (4.79
to 7.06), (P < 0.001). The Cochran’s test results indicate
for a low heterogeneity of review (Q = 23.78, df = 20,
I2 = 15.91, P = 0.252). We did not include these studies
in our meta-analysis. Table 2 shows the results of
statistical analysis of data in these studies, including
the age-standardized incidence rate and crude Inci-
dence rates split by gender.
The age-standardized incidence rates (ASRs) of colorec-
tal cancer obtained based on the random effect model
were 8.16 (95 % CI: 6.64 to 9.68) for males and 6.17 (95 %
CI: 5.01 to 7.32) for females. The Cochran’s test results in-
dicate for a substantial heterogeneity of review in both
males (Q = 68.18, df = 29, I2 = 57.69, P < 0.001) and fe-
males (Q = 48.43, df = 28, I2 = 42.19, P = 0.010). The het-
erogeneity of both analyses was in the range of moderate,
as I2 was between 30 and 60 %. (Figs. 2 and 3).
The crude incidence rates (CR) of colorectal cancer
obtained based on the random model were 5.58 (95 % CI:
4.22 to 6.94) for males and 4.01 (95 % CI: 3.06 to 4.97) for
females. The Cochran’s test results indicate for a moderate
heterogeneity of review in both males (Q = 44.04, df = 21,
I2 = 52.32, P = 0.004) and females (Q = 27.69, df = 21, I2 =
24.15, P = 0.15) (Figs. 4 and 5).
Discussion
Iran is the second-largest nation in the Middle East. It is
a large and diverse country, comprising several different
religious and ethnic groups. It is divided into five main
regions, with 31 provinces. Recently, Iran was ranked as
Fig. 1 Flow Diagram of study selection process
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Somi 2014 [15] East Azerbaijan 2007–2011 366 3724620 59.4 (±14.7) NP M:11.2 M:11.5 55/45 NP
F:8.93 F:9.22
Rouhollahi 2014 [10] Iran 2011–2013 7163 75149669 NP NP M:11.6 NP NP NP
F:10.5
Moradi Nejad 2014 [45] Hormozgan 2011 23 1578183 M:56 NP NP M:1.1 55/45 NP
F:51 F:1.2
Vakili 2014 [46] Yazd 2005–2009 NP 990818 M:60.07 (±19.49) NP 2005–2009 NP 53.5/46.5 NP
M: 6.1–9.9
F:54.93 (±18.03) F:5.2–6.0
Askarian 2014 [47] Fars 2001–2009 1531 4.6 million NP NP 9Y 9Y 58/42 NP
M:63.36 M:44.04
F:48.15 F:32.81
Amoori 2014 [48] Khouzestan 2004–2008 NP 4531720 NP NP M:11.6 NP NP NP
F:10
Overall:10.8




Rohani-Rasaf 2013 [23] Tehran 2008 NP 13422366 NP NP M:16.4 NP NP NP
F:12.2
Talaiezadeh 2013 [50] Khuzestan 2002–2009 1102 4,531,720 52.91 (±20.95) NP M:6.32 M:4.32 51.4/48.6 NP
F:5.72 F:3.45
Abdifard 2013 [6] West of Iran: 2000–2005 762 1:1945227 NP NP 2000–2005 NP NP NP
1. Kermanshah 2:1493645 1:07–6.2
2. Kordestan 3:557599 2:2.7–4.1
3. Ilam 4:175826 3:0.0–2.1
4. Hamedan Overall:575739 4:1.8–4.6
Overall:1.5–4.8
Hosseinzadeh 2012 [51] Isfahan 2009 125 4879312 58.38 (±11.64) 5.6 % Overall :2.37 NP 53.8/47.2 NP
Roshandel 2012 [30] Golestan 2004–2008 611 1640200 M:62 (±25) NP M: 12.4 M:8.34 56.4/43.6 NP














Table 1 Summary of studies for colorectal cancer rates (per 100,000) in Iran (Continued)
Safaee 2012 [16] INCRS 2005–2009 19617 70166948 58.9 (±15.4) 11 % 4Y NP 56/44 Colon: 62 %
M:39.96 Rectal: 35.1 %
F:36.16 Anus & Anal
canal: 2.9 %
Overall:38.0
Najafi 2011 [52] Kermanshah 1994–2007 665 2000000 NP NP 1993–2007 NP 59/41 NP
3.5–5.7
Overall:4.5
Rohani-Rasaf 2011 [53] Tehran 2007 509 7803883 NP NP M:13.418 M:7.324 NP NP
F:4.284 F:5.710
Overall:4.940 Overall:6.522
Haghdoost 2011 [2] Kerman 1991–2002 551 2.6 million 56.4 NP 12Y 12Y 49.9/50.1 NP
M:50 M:21
F: 53 F:22
Zendehdel 2010 [54] Iran 2004–2006 NP 70166948 NP NP M:7.1 M:6.1 NP NP
F:6.5 F:5.4
Koosha 2010 [33] East Azerbaijan 2007 208 3603456 54.97 (±18) NP M:7.98 M: 6.3 57.2/42.8 NP
F:5.67 F: 4.82
Overall:6.78 Overall:5.55
Mashhadi 2010 [24] Zahedan 2003–2006 94 2405742 51 (±19) NP 4Y NP 58/42 NP
M: 41
F: 53
Keshtkar 2009 [55] Golestan 2004–2005 47 1617087 52.2 (±13.8) 10.6 % Overall:6.26 NP NP NP
Somi 2009 [14] East Azerbaijan 2006–2007 337 3603456 M:54.53 (±14.21) NP M:11.57 M:10.2 55.4/44.6 NP
F:6.91 (±14.41) F:9.73 F:8.50
Babaei 2009 [56] Ardabil 2004–2006 241 1,228,155 59.8 (±17.8) NP M:9.6 M:7.6 59.75/40.24 NP
F:7.4 F:5.3
Ganji 2009 [57] Iran 2000–2004 1198 63741000 NP NP M: 8.3 NP 53/47 NP
F: 6.5
Overall: 7.4
Abdollahian 2009 [58] Lorestan 1999–2003 39 1754243 NP 0 % 8.94 NP 56.4/43.6 NP
















Table 1 Summary of studies for colorectal cancer rates (per 100,000) in Iran (Continued)
Mehrabani 2008 [60] Fars 1990–2005 197 4336878 NP NP M: 3.26 M:1.92 56.85/43.15 NP
F:2.41 F:1.51
Fakheri 2008 [3] Mazandaran Oct1999–Feb2008 296 2922432 52.6 (±15.24) 33.5 %(98) 8Y NP 51.35/48.65 RS: 40.2 %
Overall :10.94 LS: 18.58 %
Rectal: 42.7 %
Salari 2007 [61] Yazd 1992–1999 191 990818 NP 7.4 % Overall:5.34 NP 55.5/44.5 RS: 16.2 %
LS:35.1 %
Rectal:32.5 %
Sadjadi 2007 [38] Kerman 1996–2000 378 2004328 M:53.1 (±21.4) NP M: 5.9 M:3.9 52.64/47.36 NP
F:49.5 (±19.3) F:5.9 F:3.6
Semnani 2006 [31] Golestan 2006 139 1640200 NP NP M:16, M:10.2, 60.43/39.57 NP
F:9.2, F:6.8
Overall:12.6 Overall:8.5
Bafandeh 2006 [34] East Azerbaijan-Tabriz 1992–2005 143 3603456 53.9 (±13.3) 13.3 % Overall:10.44 NP 62.2/37.8 RS: 18.2 %
LS:39.1 %
Rectal: 42.6 %
Somi 2006 [35] East Azerbaijan 1999–2004 NP 3,500,000 M:63.3 (±12.8) NP M:6.7 M:6.0 NP NP
F:59.5 (±13.4) F:5.2 F:4.8





Pahlavan 2005 [22] 1. Ardabil 1996–2000 1628 1.1168011 NP NP 1.M:7.86 1.M:5.0 57.4/42.5 NP
2. Mazandaran 2.1740772 F:5.89 F:3.3
3. Golestan 3.1522468 2.M:9.9 2.M:8.9


















Table 1 Summary of studies for colorectal cancer rates (per 100,000) in Iran (Continued)




Babaei 2005 [63] Semnan 1998–2001 NP 293000 59.41 (±19.08) NP M: 11.62 M:10.6 54/46 NP
F: 10.52 F:8.4
Jalali 2005 [64] Iran 1981–2001 900 13422366 51.07 (±14.87) 26 % Overall :7.82 NP 58/42 RS:12.7 %
LS:22.91 %
Rectal: 64.65 %
Emami 2005 [65] Isfahan 1996–2003 1100 4559256 NP 15.2 % 7Y NP NP RS:14.1
Overall :24.95 LS:24.3 %
Rectal: 61.6 %
Yazdanbod 2004 [66] Ardabil 1996–1999 NP 1128864 NP NP M: 7.86 M:5.04 NP NP
F:5.89 F:3.33
Nikshoar 2004 [67] Iran 1992–2002 2107 13422366 NP 20.4 % 10 Y NP 55.9/44.1 RS: 13.9 %
M:20.84 LS:30.5 %
F:17.56 Rectal:55.7 %
Sadjadi 2003 [68] Ardabil 1996–1999 180 1128864 M:59.1 (±16.7) NP M: 7.9 M:5 60/40 NP
F: 5.9 F:3.3F:53.0 (±17.8)
Sarmast 2002 [39] Khuzestan 1992–1999 100 4274979 NP 30 % Overall :3.53 NP 58/42 RS:13 %
LS:42 %
Rectal:45 %
Sotoudehmanesh 2002 [69] Iran 1991–2000 380 13422366 53.9 (±15.6) 22.3 % Overall :6 NP 60.3/39.7 NP
Molanaei 2000 [70] Kurdistan 1995–1999 100 1440156 51.49 23 % 5Y NP 61/39 NP
Overall :8.82















an upper middle-income economy country by the World
Bank. According to the GLOBOCAN 2012, colorectal
cancer is the fourth most common cancer among men
and the second among women in Iran [4]. The rising
incidence and mortality rates of colorectal cancer
demand a systematic approach toward a specific and
national research program in Iran. We included in this
meta-analysis the studies reporting different measures of
incidence, age-standardized incidence rate (ASR), and
crude incidence rate (CR). The data sources were
primarily based on the Iranian National Cancer Registry
System (INCRS) database results, in which more than
85 % of the expected numbers of cancers are being
registered.
Globally, colorectal cancer is the second most com-
mon cancer in women and third in men. Although
rates differ significantly in different parts of the
world, incidence rates vary ten-fold in both genders
worldwide. North America, Western Europe, Australia
and New Zealand (with an ASR of 44.8 and 32.2 per
100,000 in males and females, respectively), have the
highest estimated incidence rates. The lowest ASR
was reported from Western Africa, with 4.5 and 3.8
per 100,000 for men and women, respectively [4].
Fig. 2 Forest Plot of random-effect meta-analysis for age standardized incidence rates in males in Iran, 95 % CI, weights are from random
effects analysis
Table 2 Summary Statistics for colorectal cancer rates (per 100,000) in Iran
Incidence
rate
Gender Effect sizes and 95 % confidence interval Heterogeneity
Number studies Point estimate Lower limit Upper limit Q-value df I-squared P-value
ASR Male 29 8.16 6.64 9.68 68.18 28 57.69 <0.001
Female 29 6.17 5.01 7.32 48.43 28 42.19 0.010
CR Male 22 5.58 4.22 6.94 44.04 21 52.32 0.002
Female 22 4.01 3.06 4.97 27.69 21 24.15 0.15
ASR age standard rate, CR crude rate
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Fig. 3 Forest Plot of random-effect meta-analysis for age standardized incidence rates in females in Iran, 95 % CI, weights are from random
effects analysis
Fig. 4 Forest Plot of random-effect meta-analysis for crude incidence rates in males in Iran, 95 % CI, weights are from random effects analysis
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Colorectal cancer is the third leading cause of can-
cer incidence and mortality in North America (North
America includes Canada) in both genders and about
245,000 new cases occur annually in United States.
The American Cancer Society(ACS) has reported the
colorectal cancer ASR as 57.2 and 42.5/100,000 in
men and women, respectively, during 2003–2007 [25].
According to the latest reports, these rates decreased
to 50.0 and 37.8 per 100,000 in males and females,
respectively, by 2011 [26]. The incidence and mortal-
ity rates have been decreasing slightly but steadily
every year, and in March 2014, ACS released data
showing that colon cancer incidence rates had
dropped by 30 % in the last decade [27].
Colorectal cancer is the second most common cancer
as reported in most European epidemiological studies.
Its incidence rates have been steadily increasing from
1984 to 2007 according to some reports [28, 29]. Mistry
et al. from United Kingdom have stated that although
the ASRs for males and females were 56.2 and 37.3,
respectively, in 2007, the incidence rate is projected to
decrease by −7 % in males. Also, ASR for 2013 was pro-
jected to decrease to 52.3for men, but this theory is not
applicable for women, according to this projection [28].
In this systematic review and meta-analysis, we included
39 studies from 2000 to 2014, from different provinces
and areas of Iran. The northern part of the country is
well-recognized to have the highest incidence of gastro-
intestinal tract cancers. The Golestan province, in north-
ern Iran, is located at the western end of Asia.
Historically, esophageal cancer(EC) incidence is very
high in this region [30]. Latest reports have shown a
decrease in EC incidence rates, but an increasing trend
in the incidence rates of CRC, and the highest overall
ASR for colorectal cancer was reported from this prov-
ince [31]. In Tehran city, the capital of Iran and the lar-
gest city in Iran and Western Asia, the incidence of CRC
is higher than the WHO estimate for Iran. Colorectal
cancer ASR has the highest rate (16.4) in males, and for
women it is 12.2. It was higher than neighboring countries
[12, 23, 32]. In an ecological study conducted in 2013 in
all the 22 districts of Tehran, an interesting correlation
between colorectal cancer incidence and different food
groups, socioeconomic position scores, and other risk
factors such as smoking was established. Colorectal cancer
was found to be more common among the higher socio-
economic position groups, with a higher prevalence of risk
factors, such as western dietary models, smoking, obesity,
and low physical activity [23].
Several reports on the ASR and CR of colorectal
cancer in East Azerbaijan province, in the North
West of Iran, are also included in this review [8, 14,
15, 33–35]. It is located in Iranian Azerbaijan, border-
ing West Azerbaijan and Turkey, with Turkish cul-
ture. There is an increasing trend in CRC incidence,
especially in females. According to our data, the high-
est CR for colorectal cancer was reported from this
province, with 11.50 cases for males, and 9.22 cases
for females. These rates are comparable with other
regions of Iran and some neighboring countries, and
should be considered in more comprehensive studies
[12, 15]. Turkey is located in Western Asia with the
portion of Eastern Thrace in southeastern Europe,
bordering Iran from the East. Based on data retrieved
Fig. 5 Forest Plot of random-effect meta-analysis for crude incidence rates in females in Iran, 95 % CI, weights are from random effects analysis
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from the Turkey Cancer Registry System, Yilmaz et
al. estimated ASRs and CRs of all cancers from 2000.
Colorectal cancer was the seventh most frequent can-
cer in both genders with lowest ASRs and CRs as
compared to our results for the same Turkish cultural
provinces of Iran. The overall ASR was about 7, and
overall crude rate was 7.51 [36, 37]. In Turkey, cancer
control programs aim to reinforce healthy nutritional
habits by education and raising public awareness.
Colorectal cancer screening programs were also intro-
duced in more restricted parts of Turkey, which seem
to be successful. Comprehensive screening programs
could be useful for future planning of colorectal can-
cer control in Iran. Timely diagnosis and removal of
adenomatous polyps may help in the prevention of
this disease. Early diagnosis of local tumors may also
improve the survival rate of patients. Educational
programs on colorectal cancer screening may increase
the overall knowledge about risk factors and screen-
ing modalities.
Several reports have shown that the ASRs and CRs of
colorectal cancer in southern Iran are lower than in the
north [2, 21, 38, 39]. The CRs in both genders were the
lowest in Hormozgan province in the southeast of Iran,
with 1.10 and 1.2, for males and females, respectively
[21]. Nutritional habits (high consumption of vegetables
and fruits), and genetic factors may play an important
role. Also because of climatic conditions, date fruit is
extensively grown and consumed in this part of Iran.
Some studies suggested that dates have a strong antioxi-
dant, which can potentially decrease the incidence and
mortality rates of most gastrointestinal tract cancers.
Recently several reports revealed an increasing inci-
dence and crude rates of colorectal cancer in Asian
countries, which was comparable with other developed
countries, especially in the younger population. West-
ernized lifestyle and diet, specifically high consumption
of red and processed meat, obesity, and low physical
activity have been established as the main cause of
increasing risk of colorectal cancer in most Asian coun-
tries. However, how westernized diet increases the risk
of cancer remains unknown, and could be due to both
genetic and epigenetic polymorphisms [40].
While colorectal cancer was the fifth most common
cancer among males, and the third in females in China
[41], it was the fourth most frequent invasive tumors
according to the data quality analysis on cancer incidence
in six cancer registries in different parts of China, includ-
ing urban and rural areas. The overall ASRs and CRs were
respectively 14.61 and 21.33, in urban areas, and 11.09
and 12.43 in rural areas. This suggests other potential
causes such as public education, promotion of healthy life-
styles and socioeconomic factors [42] . Hong Kong had a
higher ASR and CR of colorectal cancer in recent years,
and an increasing trend from 1983 to 2006. The overall
crude rate was 57.1, and ASR was markedly higher in men
than in women (68.2 and 47.1, respectively) [40].
In Lebanon, a small middle-income country on the
Eastern Mediterranean shore, the ASRs for colon cancer in
both genders are slightly higher than our and other results.
Colon cancer was the fourth most common cancer among
males, with ASR of 15.3, while it was the second in females
with ASR of 14.1. The ASRs for rectal cancer were 4.2 and
4.8 in men and women, respectively. The higher ASRs for
both colon and rectal cancers may be attributed to the
highest elderly population in Lebanon among other Arab
countries [43]. According to Saudi Cancer Registry in re-
cent years, colorectal cancer was the most common cancer
among men and the third in women. The overall ASR was
9.6, with 9.9 for men and 9.2 for women, which were simi-
lar to our rates in Iran [44].
Limitation
The data sources for this study were primarily based on
the INCRS database results, in which more than 85 % of
the expected numbers of cancers are being registered.
However, we did not have access to data from all cities
and rural areas of the country.
Conclusions
Colorectal cancer incidence rates rise due to individual
and environmental risk factors as well as improvement
in the registry system and increase in access to health
services. Ageing population is often assumed to be the
main factor driving an increase in colorectal cancer inci-
dence and mortality rates; however the actual scenario is
more complex. In developed countries, age-standardized
mortality rates of cancer are now significantly decreasing
in all age groups.
A more executed system for collecting cancer data, in
all cities and rural areas of the country, is an essential
priority. We emphasize monitoring the burden of colo-
rectal cancer and increasing public awareness and atti-
tudes toward the risk factors and prevention of cancer.
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